U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Approval Year

2002
144
Substance Class Protein
Created
by admin
on Mon Mar 31 23:46:00 GMT 2025
Edited
by admin
on Mon Mar 31 23:46:00 GMT 2025
Protein Sub Type
Sequence Type COMPLETE
Record UNII
3A58010674
Record Status Validated (UNII)
Record Version
  • Download
Related Record Type
Name Type Language
PEGFILGRASTIM
EMA EPAR   INN   MART.   USAN   VANDF   WHO-DD  
INN   USAN  
Official Name English
PEGFILGRASTIM, LICENSE HOLDER UNSPECIFIED
Preferred Name English
PEGFILGRASTIM [USAN]
Common Name English
Pegfilgrastim [WHO-DD]
Common Name English
PEGFILGRASTIM [EMA EPAR]
Common Name English
PEGFILGRASTIM FOR BIOASSAY
USP-RS  
Common Name English
GRANULOCYTE COLONY-STIMULATING FACTOR PEGFILGRASTIM [MI]
Common Name English
PEGFILGRASTIM [JAN]
Common Name English
Pegylated granulocyte colony stimulating factor
Common Name English
NEUPOPEG
Brand Name English
pegfilgrastim [INN]
Common Name English
PEGFILGRASTIM [MART.]
Common Name English
Pegylated granulocyte colony stimulating factor [WHO-DD]
Common Name English
N-(3-HYDROXYPROPYL)METHIONYLCOLONY-STIMULATING FACTOR (HUMAN), 1-ETHER WITH .ALPHA.-METHYL-.OMEGA.-HYDROXYPOLY(OXYETHYLENE)
Common Name English
PEGFILGRASTIM FOR BIOASSAY [USP-RS]
Common Name English
GRANULOCYTE COLONY-STIMULATING FACTOR PEGFILGRASTIM
MI  
Common Name English
PEGFILGRASTIM [PURPLE BOOK CDER]
Common Name English
PEG-FILGRASTIM
Common Name English
PEGFILGRASTIM [VANDF]
Common Name English
Classification Tree Code System Code
EMA ASSESSMENT REPORTS NEUPOPEG (WITHDRAWN: NEUTROPENIA)
Created by admin on Mon Mar 31 23:46:00 GMT 2025 , Edited by admin on Mon Mar 31 23:46:00 GMT 2025
NDF-RT N0000008191
Created by admin on Mon Mar 31 23:46:00 GMT 2025 , Edited by admin on Mon Mar 31 23:46:00 GMT 2025
NDF-RT N0000009451
Created by admin on Mon Mar 31 23:46:00 GMT 2025 , Edited by admin on Mon Mar 31 23:46:00 GMT 2025
NDF-RT N0000008192
Created by admin on Mon Mar 31 23:46:00 GMT 2025 , Edited by admin on Mon Mar 31 23:46:00 GMT 2025
NDF-RT N0000008191
Created by admin on Mon Mar 31 23:46:00 GMT 2025 , Edited by admin on Mon Mar 31 23:46:00 GMT 2025
NDF-RT N0000008192
Created by admin on Mon Mar 31 23:46:00 GMT 2025 , Edited by admin on Mon Mar 31 23:46:00 GMT 2025
NCI_THESAURUS C387
Created by admin on Mon Mar 31 23:46:00 GMT 2025 , Edited by admin on Mon Mar 31 23:46:00 GMT 2025
NDF-RT N0000008191
Created by admin on Mon Mar 31 23:46:00 GMT 2025 , Edited by admin on Mon Mar 31 23:46:00 GMT 2025
FDA ORPHAN DRUG 413013
Created by admin on Mon Mar 31 23:46:00 GMT 2025 , Edited by admin on Mon Mar 31 23:46:00 GMT 2025
NDF-RT N0000008191
Created by admin on Mon Mar 31 23:46:00 GMT 2025 , Edited by admin on Mon Mar 31 23:46:00 GMT 2025
WHO-ATC L03AA13
Created by admin on Mon Mar 31 23:46:00 GMT 2025 , Edited by admin on Mon Mar 31 23:46:00 GMT 2025
NDF-RT N0000008192
Created by admin on Mon Mar 31 23:46:00 GMT 2025 , Edited by admin on Mon Mar 31 23:46:00 GMT 2025
NDF-RT N0000008191
Created by admin on Mon Mar 31 23:46:00 GMT 2025 , Edited by admin on Mon Mar 31 23:46:00 GMT 2025
NDF-RT N0000008192
Created by admin on Mon Mar 31 23:46:00 GMT 2025 , Edited by admin on Mon Mar 31 23:46:00 GMT 2025
NDF-RT N0000175666
Created by admin on Mon Mar 31 23:46:00 GMT 2025 , Edited by admin on Mon Mar 31 23:46:00 GMT 2025
EMA ASSESSMENT REPORTS RISTEMPA (AUTHORIZED: NEUTROPENIA)
Created by admin on Mon Mar 31 23:46:00 GMT 2025 , Edited by admin on Mon Mar 31 23:46:00 GMT 2025
WHO-VATC QL03AA13
Created by admin on Mon Mar 31 23:46:00 GMT 2025 , Edited by admin on Mon Mar 31 23:46:00 GMT 2025
NDF-RT N0000008192
Created by admin on Mon Mar 31 23:46:00 GMT 2025 , Edited by admin on Mon Mar 31 23:46:00 GMT 2025
LIVERTOX 745
Created by admin on Mon Mar 31 23:46:00 GMT 2025 , Edited by admin on Mon Mar 31 23:46:00 GMT 2025
EMA ASSESSMENT REPORTS NEULASTA (AUTHORIZED: NEUTROPENIA)
Created by admin on Mon Mar 31 23:46:00 GMT 2025 , Edited by admin on Mon Mar 31 23:46:00 GMT 2025
Code System Code Type Description
RXCUI
2102692
Created by admin on Mon Mar 31 23:46:00 GMT 2025 , Edited by admin on Mon Mar 31 23:46:00 GMT 2025
ALTERNATIVE
DAILYMED
3A58010674
Created by admin on Mon Mar 31 23:46:00 GMT 2025 , Edited by admin on Mon Mar 31 23:46:00 GMT 2025
PRIMARY
MERCK INDEX
m5843
Created by admin on Mon Mar 31 23:46:00 GMT 2025 , Edited by admin on Mon Mar 31 23:46:00 GMT 2025
PRIMARY Merck Index
EVMPD
SUB16451MIG
Created by admin on Mon Mar 31 23:46:00 GMT 2025 , Edited by admin on Mon Mar 31 23:46:00 GMT 2025
PRIMARY
USAN
LL-106
Created by admin on Mon Mar 31 23:46:00 GMT 2025 , Edited by admin on Mon Mar 31 23:46:00 GMT 2025
PRIMARY
ChEMBL
CHEMBL1201568
Created by admin on Mon Mar 31 23:46:00 GMT 2025 , Edited by admin on Mon Mar 31 23:46:00 GMT 2025
PRIMARY
NCI_THESAURUS
C1854
Created by admin on Mon Mar 31 23:46:00 GMT 2025 , Edited by admin on Mon Mar 31 23:46:00 GMT 2025
PRIMARY
SMS_ID
100000089834
Created by admin on Mon Mar 31 23:46:00 GMT 2025 , Edited by admin on Mon Mar 31 23:46:00 GMT 2025
PRIMARY
WIKIPEDIA
Pegfilgrastim
Created by admin on Mon Mar 31 23:46:00 GMT 2025 , Edited by admin on Mon Mar 31 23:46:00 GMT 2025
PRIMARY
RXCUI
2048018
Created by admin on Mon Mar 31 23:46:00 GMT 2025 , Edited by admin on Mon Mar 31 23:46:00 GMT 2025
ALTERNATIVE
FDA UNII
3A58010674
Created by admin on Mon Mar 31 23:46:00 GMT 2025 , Edited by admin on Mon Mar 31 23:46:00 GMT 2025
PRIMARY
RXCUI
2260702
Created by admin on Mon Mar 31 23:46:00 GMT 2025 , Edited by admin on Mon Mar 31 23:46:00 GMT 2025
ALTERNATIVE
RXCUI
338036
Created by admin on Mon Mar 31 23:46:00 GMT 2025 , Edited by admin on Mon Mar 31 23:46:00 GMT 2025
PRIMARY RxNorm
IUPHAR
6969
Created by admin on Mon Mar 31 23:46:00 GMT 2025 , Edited by admin on Mon Mar 31 23:46:00 GMT 2025
PRIMARY
INN
8114
Created by admin on Mon Mar 31 23:46:00 GMT 2025 , Edited by admin on Mon Mar 31 23:46:00 GMT 2025
PRIMARY
DRUG BANK
DB00019
Created by admin on Mon Mar 31 23:46:00 GMT 2025 , Edited by admin on Mon Mar 31 23:46:00 GMT 2025
PRIMARY
HSDB
8157
Created by admin on Mon Mar 31 23:46:00 GMT 2025 , Edited by admin on Mon Mar 31 23:46:00 GMT 2025
PRIMARY
CAS
208265-92-3
Created by admin on Mon Mar 31 23:46:00 GMT 2025 , Edited by admin on Mon Mar 31 23:46:00 GMT 2025
PRIMARY
MESH
C423652
Created by admin on Mon Mar 31 23:46:00 GMT 2025 , Edited by admin on Mon Mar 31 23:46:00 GMT 2025
PRIMARY
MESH
C455861
Created by admin on Mon Mar 31 23:46:00 GMT 2025 , Edited by admin on Mon Mar 31 23:46:00 GMT 2025
PRIMARY
DRUG CENTRAL
4986
Created by admin on Mon Mar 31 23:46:00 GMT 2025 , Edited by admin on Mon Mar 31 23:46:00 GMT 2025
PRIMARY
From To
1_37 1_43
1_65 1_75
Related Record Type Details
PEGFILGRASTIM-PBBK
SUB_CONCEPT->SUBSTANCE
FILGRASTIM
PARENT -> CONJUGATE
QL-0605
SUB_CONCEPT->SUBSTANCE
QL-0605
BIOSIMILAR -> PARENT
PEGFILGRASTIM-BMEZ
SUB_CONCEPT->SUBSTANCE
Pegfilgrastim-FPGK
SUB_CONCEPT->SUBSTANCE
PEGFILGRASTIM-PBBK
BIOSIMILAR -> PARENT
PEGFILGRASTIM BIOSIMILAR (MUNDIPHARMA)
SUB_CONCEPT->SUBSTANCE
GRANULOCYTE COLONY-STIMULATING FACTOR RECEPTOR
TARGET -> AGONIST
Pegfilgrastim-FPGK
BIOSIMILAR -> PARENT
PEGFILGRASTIM (NEULASTA)
SUB_CONCEPT->SUBSTANCE
PEGFILGRASTIM BIOSIMILAR (MUNDIPHARMA)
BIOSIMILAR -> PARENT
PEGFILGRASTIM BIOSIMILAR (LUPIN)
SUB_CONCEPT->SUBSTANCE
PEGFILGRASTIM-JMDB
BIOSIMILAR -> PARENT
PEGFILGRASTIM-CBQV
SUB_CONCEPT->SUBSTANCE
PEGFILGRASTIM-APGF
SUB_CONCEPT->SUBSTANCE
PEGFILGRASTIM-BMEZ
BIOSIMILAR -> PARENT
PEGFILGRASTIM-CBQV
BIOSIMILAR -> PARENT
PEGFILGRASTIM-JMDB
SUB_CONCEPT->SUBSTANCE
PEGFILGRASTIM-APGF
BIOSIMILAR -> PARENT
Related Record Type Details
PEGFILGRASTIM
ACTIVE MOIETY

Structural Modifications

Modification Type Location Site Location Type Residue Modified Extent Fragment Name Fragment Approval
AMINO_ACID_SUBSTITUTION [1_1] N-TERMINUS M Amount: N-(MPEG-20000-PROPYL)-METHIONINE XQ9T6997VF
Name Property Type Amount Referenced Substance Defining Parameters References
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL
Molecular Formula CHEMICAL
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966